計算生物学の市場規模、シェア、成長分析、用途別、最終用途別、サービス別、地域別 - 産業別予測、2024～2031年

計算生物学の世界市場規模は、2022年に57億米ドルと評価され、2023年の67億5,000万米ドルから2031年には262億6,000万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは18.5%で成長する見通しです。

計算生物学市場は、創薬研究開発の増加、予測モデルに対する需要の急増、政府による資金援助イニシアティブなどを背景に急成長を遂げています。理論的概念とコンピュータ・シミュレーションを活用するこの学際的分野では、ゲノム学や薬理学を含む生物学的システムの詳細な探索が可能です。注目すべき進歩としては、遺伝子マッピングにおけるコンピュータの威力を示したヒトゲノムプロジェクトが挙げられます。BeiGeneとAmbrxのような共同研究は、拡張遺伝暗号のような革新的なプラットフォームを統合することで、医薬品開発を強化しています。臨床試験におけるコストと失敗率の上昇に対応するため、製薬会社は予測モデリングにシフトしており、市場は大きく拡大する態勢にあります。官民両部門からの投資の増加は、このダイナミックな分野を強化し続けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢

計算生物学市場規模：サービス別およびCAGR（2024～2031年）

• 市場概要
• データベース
• インフラストラクチャとハードウェア
• ソフトウェアプラットフォーム

計算生物学市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 創薬と疾患モデル化
  • ターゲット識別
  • ターゲット検証
  • リード発見
  • リード最適化
• 前臨床医薬品開発
  • 薬物動態
  • 薬力学
• 臨床試験
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV
• 計算ゲノム科学
• 計算プロテオミクス
• その他

計算生物学市場規模：最終用途別およびCAGR（2024～2031年）

• 市場概要
• 学術調査
• 製薬業界
• 産業

計算生物学市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• DNAnexus, Inc.
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Schrodinger, Inc.
• Compugen
• Aganitha AI Inc.
• Genedata AG
• QIAGEN
• Simulations Plus, Inc.
• Fios Genomics
• Certara
• Chemical Computing Group ULC
• Dassault Systemes
• Genedata AG
• Insilico Biotechnology AG

結論と推奨事項

Global Computational Biology Market size was valued at USD 5.7 billion in 2022 and is poised to grow from USD 6.75 billion in 2023 to USD 26.26 billion by 2031, growing at a CAGR of 18.5% during the forecast period (2024-2031).

The computational biology market is experiencing rapid growth, driven by increasing drug discovery R&D, a surge in demand for predictive models, and government funding initiatives. Leveraging theoretical concepts and computer simulations, this multidisciplinary field enables detailed exploration of biological systems, including genomics and pharmacology. Notable advancements include the Human Genome Project, which showcased the power of computing in genetic mapping. Collaborations, such as that between BeiGene and Ambrx, are enhancing drug development by integrating innovative platforms like the Expanded Genetic Code. With pharmaceutical companies shifting towards predictive modeling in response to rising costs and failure rates in clinical trials, the market is poised for significant expansion. Increased investment from both public and private sectors continues to bolster this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segmental Analysis

Global Computational Biology Market is segmented by service, application, end-use and region. Based on service, the market is segmented into databases, infrastructure & hardware and software platform. Based on application, the market is segmented into drug discovery & disease modelling, preclinical drug development, clinical trial, computational genomics, computational proteomics and others. Based on end-use, the market is segmented into academic & research, pharmaceutical industry and industrial. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The global Computational Biology market is projected to witness significant growth driven by the increasing demand for advanced computational tools for genome sequencing. As more sophisticated software becomes accessible, scientists can efficiently conduct tasks such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acids. The expanding databases and sequence analysis tools empower researchers to extract valuable insights regarding gene structures and functions, thereby enhancing the drug development process. By pinpointing functionally relevant protein sequences from extensive datasets, these computational approaches facilitate the discovery of new therapeutic targets and enable the engineering of synthetic DNA sequences, which further promotes innovation and commercialization in biotechnology. This rapid advancement in sequencing technology and analytical tools is expected to substantially boost market revenue in the coming years.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a scarcity of skilled professionals and a lack of standardized practices. Expertise in this field requires a strong foundation in programming, mathematics, and statistics, along with a comprehensive understanding of cloud computing and biological sciences. The interdisciplinary nature of computational biology often results in an absence of a cohesive curriculum, which may impede the ability of recent graduates to enhance their skill sets effectively. Furthermore, the field currently lacks established methods for addressing issues such as allergic reactions and post-surgical complications, potentially hindering market revenue growth in the future.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing a robust upward trend, primarily fueled by the surge in clinical studies focused on pharmacogenomics, which enhances understanding of diverse patient populations' biological frameworks. This growing emphasis on personalized medicine, along with the need for rapid drug discovery and streamlined scientific research processes, is driving demand for computational biology solutions. Moreover, the increasing integration of computational tools across epigenomics, proteomics, and metagenomics sectors is pivotal in elucidating protein structures and interactions. Coupled with significant advancements in disease modeling and drug development, alongside heightened R&D investment from both private and public entities, the market is poised for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Computational Biology Market Size by Service & CAGR (2024-2031)

• Market Overview
• Databases
• Infrastructure & Hardware
• Software Platform

Global Computational Biology Market Size by Application & CAGR (2024-2031)

• Market Overview
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trial
  • Phase I
  • Phase Ii
  • Phase Iii
  • Phase Iv
• Computational Genomics
• Computational Proteomics
• Others

Global Computational Biology Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research
• Pharmaceutical Industry
• Industrial

Global Computational Biology Market Size & CAGR (2024-2031)

• North America (Service, Application, End-Use)
  • USA
  • Canada
• Europe (Service, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• DNAnexus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compugen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aganitha AI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simulations Plus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fios Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group ULC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Biotechnology AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations